GSI characterized the acquisition as just one step in a "medical component market strategy, which has been in process for over a year," but also as complementary to GSI's existing lines of medical products. In a press release, the company noted that it has a "number of shared customers [with NDS], which we expect will strengthen the Company's key OEM customer relationships."
Going forward, the company says it expects "nearly 40%" of its revenues to come from the medical market. The NDS transaction in particular is expected to produce $80 million in annual revenue and to be accretive to GSI's earnings in 2013.
Shares of GSI rose 10.3% on the news to $9.34.
Rich Smith and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.